Fujifilm Holdings Corporation (FUJIY):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Fujifilm Holdings Corporation (FUJIY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11513
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fujifilm Holdings Corp (Fujifilm) sales and manufactures imaging systems and document solution equipment. The company’s major products are color films, color paper and chemicals, photofinishing equipment, electronic imaging and optical devices, TV camera lenses, security lenses, healthcare products, graphic systems, flat panel display materials, recording media and industrial products. It also offers document solutions such as office products, office printers, and allied production services and global services. The company serves individual consumers and business enterprises. Its two major operating subsidiaries include FUJIFILM Corporation and Fuji Xerox Co. Ltd. The company conducts business operations in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. Fujifilm is headquartered in Tokyo, Japan.

Fujifilm Holdings Corporation (FUJIY) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Fujifilm Holdings Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Fujifilm Holdings Corporation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Fujifilm Holdings Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Fujifilm Holdings Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Fujifilm Holdings Corporation, Medical Devices Deals, 2012 to YTD 2018 11
Fujifilm Holdings Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Fujifilm Holdings Corporation, Pharmaceuticals & Healthcare, Deal Details 15
Partnerships 15
FUJIFILM Diosynth Biotechnologies and Centre for Process Innovation Enter into Collaboration Agreement 15
Fujifilm to Enter into Partnership with Zhejiang Hisun Pharma, China-Japan Friendship Clinic and National Engineering Research Center 16
Fujifilm and Takeda Pharma Enter into Agreement 17
RegenxBio Enters into Agreement with Fujifilm Diosynth Biotechnologies 18
EdiGene Enters into Research Agreement with Fujifilm 19
CanBas Enters into Research Agreement with Fujifilm 20
FunPep Enters into Research Agreement with Fujifilm 21
China Resources Holdings Enter into Agreement with Fujifilm Holdings 22
China Resources Pharmaceutical Enters into Agreement with Fujifilm 23
AdAlta Enters into Agreement with FujiFilm Diosynth 24
Cynata Therapeutics to Enter into Co-Development Agreement with Fujifilm 25
Fujifilm Diosynth Biotech Partners with Merck 26
Bioaster Partners with Fujifilm 27
Fujifilm Enters into Co-Marketing Agreement with Shenzhen Main Luck Pharma 28
Sosei Enters Into Distribution Agreement With Fujifilm Pharma For SO-1105 29
Masthercell Forms Joint Venture with Kalon 30
Fujifilm Diosynth Biotech Enters Into Agreement With Piramal Healthcare To Develop Antibody Drug Conjugates 31
Yokogawa Electric Enters Into Co-Marketing Agreement With Wako Pure Chemical Industries For CellVoyager CV7000 32
FUJIFILM Forms Joint Venture With Kyowa Hakko Kirin 33
Licensing Agreements 35
FUJIFILM Cellular Dynamics Enters into Licensing Agreement with University of California Irvine 35
TR-Pharm Enters into Licensing Agreement with Toyama Chemical 36
Fujifilm RI Pharma Enters into Licensing Agreement with Advanced Accelerator Applications 37
Cempra Enters Into Licensing And Development Agreement With Toyama Chemical For Solithromycin 38
Zhejiang Hisun Pharma Enters into Licensing Agreement with Fujifilm 40
Equity Offering 41
Suono Bio Raises Funds through Private Placement 41
Fujifilm to Invest USD3.4 Million in Cyfuse Biomedical 42
Fujifilm Invests USD0.3 Million in Japan Biomedical 43
Fujifilm Invests USD1.5 Million in Regcell 44
Asset Transactions 45
Eisai to Acquire Rights of Kolbet from Toyoma Chemical and Taisho Pharma 45
Acquisition 46
Fujifilm Holdings to Acquire Additional 34% Stake in Toyama Chemical 46
Fujifilm Acquires 11.7% Stake in EdiGene 47
Fujifilm Acquires 6% stake in NC Medical Research for USD3.8 Million 48
Fujifilm Acquires Cellular Dynamics for USD238 Million in Tender Offer 49
Fujifilm Diosynth Biotech Acquires 49% Stake in Kalon Biotherapeutics 51
Fujifilm Holdings Corporation – Key Competitors 52
Fujifilm Holdings Corporation – Key Employees 53
Fujifilm Holdings Corporation – Locations And Subsidiaries 54
Head Office 54
Other Locations & Subsidiaries 54
Recent Developments 56
Product News 56
11/13/2018: Research results for FF-10850, a novel liposome drug candidate for improvement of pharmacological efficacy through selective delivery of anti-cancer agent to tumors 56
02/22/2018: New Manufacturing Facility to be Built at Toyama Chemical, a Fujifilm Company 58
Clinical Trials 59
Aug 30, 2017: Clinical Trials of Anti-cancer Agent FF-10832 to start in the US for Advanced Solid Tumors 59
Aug 08, 2017: Fujifilm initiates a Phase I clinical trial of Anti-Cancer Drug FF-10101 in the United States in patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) 60
Appendix 61
Methodology 61
About GlobalData 61
Contact Us 61
Disclaimer 61

List of Tables
Fujifilm Holdings Corporation, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Fujifilm Holdings Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Fujifilm Holdings Corporation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Fujifilm Holdings Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Fujifilm Holdings Corporation, Deals By Therapy Area, 2012 to YTD 2018 10
Fujifilm Holdings Corporation, Medical Devices Deals, 2012 to YTD 2018 11
Fujifilm Holdings Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
FUJIFILM Diosynth Biotechnologies and Centre for Process Innovation Enter into Collaboration Agreement 15
Fujifilm to Enter into Partnership with Zhejiang Hisun Pharma, China-Japan Friendship Clinic and National Engineering Research Center 16
Fujifilm and Takeda Pharma Enter into Agreement 17
RegenxBio Enters into Agreement with Fujifilm Diosynth Biotechnologies 18
EdiGene Enters into Research Agreement with Fujifilm 19
CanBas Enters into Research Agreement with Fujifilm 20
FunPep Enters into Research Agreement with Fujifilm 21
China Resources Holdings Enter into Agreement with Fujifilm Holdings 22
China Resources Pharmaceutical Enters into Agreement with Fujifilm 23
AdAlta Enters into Agreement with FujiFilm Diosynth 24
Cynata Therapeutics to Enter into Co-Development Agreement with Fujifilm 25
Fujifilm Diosynth Biotech Partners with Merck 26
Bioaster Partners with Fujifilm 27
Fujifilm Enters into Co-Marketing Agreement with Shenzhen Main Luck Pharma 28
Sosei Enters Into Distribution Agreement With Fujifilm Pharma For SO-1105 29
Masthercell Forms Joint Venture with Kalon 30
Fujifilm Diosynth Biotech Enters Into Agreement With Piramal Healthcare To Develop Antibody Drug Conjugates 31
Yokogawa Electric Enters Into Co-Marketing Agreement With Wako Pure Chemical Industries For CellVoyager CV7000 32
FUJIFILM Forms Joint Venture With Kyowa Hakko Kirin 33
FUJIFILM Cellular Dynamics Enters into Licensing Agreement with University of California Irvine 35
TR-Pharm Enters into Licensing Agreement with Toyama Chemical 36
Fujifilm RI Pharma Enters into Licensing Agreement with Advanced Accelerator Applications 37
Cempra Enters Into Licensing And Development Agreement With Toyama Chemical For Solithromycin 38
Zhejiang Hisun Pharma Enters into Licensing Agreement with Fujifilm 40
Suono Bio Raises Funds through Private Placement 41
Fujifilm to Invest USD3.4 Million in Cyfuse Biomedical 42
Fujifilm Invests USD0.3 Million in Japan Biomedical 43
Fujifilm Invests USD1.5 Million in Regcell 44
Eisai to Acquire Rights of Kolbet from Toyoma Chemical and Taisho Pharma 45
Fujifilm Holdings to Acquire Additional 34% Stake in Toyama Chemical 46
Fujifilm Acquires 11.7% Stake in EdiGene 47
Fujifilm Acquires 6% stake in NC Medical Research for USD3.8 Million 48
Fujifilm Acquires Cellular Dynamics for USD238 Million in Tender Offer 49
Fujifilm Diosynth Biotech Acquires 49% Stake in Kalon Biotherapeutics 51
Fujifilm Holdings Corporation, Key Competitors 52
Fujifilm Holdings Corporation, Key Employees 53
Fujifilm Holdings Corporation, Subsidiaries 54

List of Figures
Fujifilm Holdings Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Fujifilm Holdings Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Fujifilm Holdings Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Fujifilm Holdings Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Fujifilm Holdings Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Fujifilm Holdings Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8
Fujifilm Holdings Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Fujifilm Holdings Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Fujifilm Holdings Corporation, Medical Devices Deals, 2012 to YTD 2018 11

★海外企業調査レポート[Fujifilm Holdings Corporation (FUJIY):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Shimano Inc (7309):企業の財務・戦略的SWOT分析
    Shimano Inc (7309) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Diana S.A.S.:企業の戦略・SWOT・財務情報
    Diana S.A.S. - Strategy, SWOT and Corporate Finance Report Summary Diana S.A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Frito-Lay North America, Inc.:企業の戦略・SWOT・財務情報
    Frito-Lay North America, Inc. - Strategy, SWOT and Corporate Finance Report Summary Frito-Lay North America, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Inditex SA (ITX):企業の財務・戦略的SWOT分析
    Inditex SA (ITX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Myriad Group AG:企業の戦略的SWOT分析
    Myriad Group AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Global Bioenergies SA (ALGBE):企業の財務・戦略的SWOT分析
    Global Bioenergies SA (ALGBE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Kawasaki Heavy Industries Ltd (7012):企業の財務・戦略的SWOT分析
    Kawasaki Heavy Industries Ltd (7012) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Intracom Holdings SA (INTRK):企業の財務・戦略的SWOT分析
    Intracom Holdings SA (INTRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Bellicum Pharmaceuticals Inc (BLCM):製薬・医療:M&Aディール及び事業提携情報
    Summary Bellicum Pharmaceuticals, Inc. (Bellicum) is a clinical stage biopharmaceutical company, which is engaged in developing cellular immunotherapies for the treatment of cancer. The company develops its product candidates through its chemical induction of dimerization technology platforms in the …
  • Grunenthal GmbH:企業の戦略的SWOT分析
    Grunenthal GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Nippon Soda Co Ltd (4041):企業の財務・戦略的SWOT分析
    Nippon Soda Co Ltd (4041) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Dedeman Hotels & Resorts International:企業の戦略・SWOT・財務分析
    Dedeman Hotels & Resorts International - Strategy, SWOT and Corporate Finance Report Summary Dedeman Hotels & Resorts International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Lyft Inc (LYFT):企業の財務・戦略的SWOT分析
    Lyft Inc (LYFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Siem Offshore Inc (SIOFF):企業の財務・戦略的SWOT分析
    Summary Siem Offshore Inc (Siem Offshore), a subsidiary of Siem Industries Inc is a marine service provider that owns and operates modern offshore support vessels for the offshore oil and gas industries. The company offers shipbuilding, ordering and delivery of new vessels, acquisition of modern sec …
  • Bengal Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Bengal Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Bengal Energy Ltd (Bengal Energy), formerly Avery Resources Inc is an oil and gas exploration and production company that acquires, explores, and produces prospective light oil-weighted onshore assets …
  • The Hain Celestial Group Inc (HAIN):企業の財務・戦略的SWOT分析
    The Hain Celestial Group Inc (HAIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Lincoln Electric Holdings Inc:企業の戦略・SWOT・財務分析
    Lincoln Electric Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Lincoln Electric Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Koncar – Elektroindustrija dd (KOEI-R-A):企業の財務・戦略的SWOT分析
    Summary Koncar - Elektroindustrija dd (Koncar) is an electrical equipment company that designs and develops power transmission, generation, distribution plants, and others. The company provides products such as electric vehicles, hydro power plant, accompanying equipment, electric traction plants, e …
  • The InterTech Group, Inc.:企業の戦略的SWOT分析
    The InterTech Group, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • The Northwestern Mutual Life Insurance Company:戦略・SWOT・企業財務分析
    The Northwestern Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary The Northwestern Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆